Case Number:

IPR2025-00210

Case Type:

IPR

Status:

Institution Denied

Petitioner:

Azurity Pharmaceuticals, Inc.

1. Filed: November 18, 2024 00:00

   Coverage

   1. June 06, 2025

      Exelixis Escapes Cancer Drug Invalidity Bid At PTAB

      Exelixis has beaten back a challenge to one of its patents covering the blockbuster drug Cabometyx after the Patent Trial and Appeal Board denied Azurity Pharmaceuticals' request to review the patent.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login